(Q34071627)

30 July 2017

1 reference

title

Multinational cooperation in trials and guidelines dealing with febrile neutropenia (English)

1 reference

30 July 2017

1 reference

Feld R

1

1 reference

30 July 2017

publication date

1 October 2000

1 reference

International Journal of Antimicrobial Agents

30 July 2017

published in

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

185-187

1 reference

Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900240-5

7 January 2021

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900240-5

7 January 2021

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900240-5

7 January 2021

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900240-5

7 January 2021

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900240-5

7 January 2021

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900240-5

7 January 2021

10.1016/S0924-8579(00)00240-5

Identifiers

DOI

1 reference

30 July 2017

1 reference